Analysis of the Recovery of Cryopreserved and Thawed CD34+ and CD3+ Cells Collected for Hematopoietic Transplantation

Overview

Journal Transfusion

Specialty Hematology

Date 2013 Oct 15

PMID 24117879

Citations 8

Authors

Virginia Fisher

Hanh Khuu

Virginia David-Ocampo

Karen Byrne

Steven Pavletic

Michael Bishop

Daniel H Fowler

A John Barrett

David F Stroncek

Affiliations

Soon will be listed here.

Abstract

Background: Cryopreservation is often used to store cellular therapies, but little is known about how well CD3+ or CD34+ cells tolerate this process.

Study Design And Methods: Viable CD34+ cell recoveries were analyzed from related and unrelated donor granulocyte-colony-stimulating factor (G-CSF)-mobilized peripheral blood stem cell (PBSC) products and viable CD3+ cell recoveries from G-CSF-mobilized and nonmobilized apheresis products from related and unrelated donors. All products were cryopreserved with 5% dimethyl sulfoxide and 6% pentastarch using a controlled-rate freezer and were stored in liquid nitrogen. Related donor products were cryopreserved immediately after collection and unrelated donor products greater than 12 hours postcollection.

Results: The postthaw recovery of CD34+ cells from related donor PBSCs was high (n = 86; 97.5 ± 23.1%) and there was no difference in postthaw CD34+ cell recovery from unrelated donor PBSCs (n = 14; 98.8 ± 37.2%; p = 0.863). In related donor lymphocyte products the postthaw CD3+ cell recovery (n = 48; 90.7 ± 21.4%) was greater than that of unrelated donor products (n = 14; 66.6 ± 35.8%; p = 0.00251). All unrelated donor lymphocyte products were from G-CSF-mobilized products, while most related donor lymphocyte products were from nonmobilized products. A comparison of the CD3+ cell recovery from related donor G-CSF-mobilized products (n = 19; 85.0 ± 29.2%) with that of unrelated donor products found no significant difference (p = 0.137).

Conclusions: The postthaw recovery of CD34+ cells was high in both related and unrelated donor products, but the recovery of CD3+ cells in unrelated donor G-CSF-mobilized products was lower. G-CSF-mobilized unrelated donor products may contain fewer CD3+ cells than non-G-CSF-exposed products upon thaw and, when indicated, cell doses should be monitored.

Citing Articles

Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients.

van der Zouwen B, Koster E, von dem Borne P, Oosten L, Roza-Scholten M, Snijders T Ann Hematol. 2023; 102(5):1203-1213.

PMID: 36881136 PMC: 10102042. DOI: 10.1007/s00277-023-05145-1.

Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular Immunotherapy.

Abdel-Azim H, Dave H, Jordan K, Rawlings-Rhea S, Luong A, Wilson A Cytotherapy. 2021; 24(2):193-204.

PMID: 34711500 PMC: 8792313. DOI: 10.1016/j.jcyt.2021.08.007.

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution.

Maurer K, Kim H, Kuczmarski T, Garrity H, Weber A, Reynolds C Blood Adv. 2021; 5(23):5140-5149.

PMID: 34581754 PMC: 9153034. DOI: 10.1182/bloodadvances.2021005139.

Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.

Jacob R, Flynn J, Devlin S, Maloy M, Giralt S, Maslak P Transplant Cell Ther. 2021; 27(8):697.e1-697.e5.

PMID: 33991721 PMC: 8316317. DOI: 10.1016/j.jtct.2021.04.026.

Mfarrej B, Lemarie C, Granata A, Pagliardini T, Malenfant C, Lignee P Bone Marrow Transplant. 2021; 56(8):2013-2015.

PMID: 33846562 PMC: 8040015. DOI: 10.1038/s41409-020-01208-3.

References

Abrahamsen J, Rusten L, Bakken A, Bruserud O . Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide. Transfusion. 2004; 44(5):785-9. DOI: 10.1111/j.1537-2995.2004.03336.x. View

Lazarus H, Kan F, Tarima S, Champlin R, Confer D, Frey N . Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. Biol Blood Marrow Transplant. 2009; 15(5):589-96. PMC: 2688780. DOI: 10.1016/j.bbmt.2009.01.017. View

Tayebi H, Kuttler F, Saas P, Lienard A, Petracca B, Lapierre V . Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp Hematol. 2001; 29(4):458-70. DOI: 10.1016/s0301-472x(01)00613-0. View

Stroncek D, Xing L, Chau Q, Zia N, McKelvy A, Pracht L . Stability of cryopreserved white blood cells (WBCs) prepared for donor WBC infusions. Transfusion. 2011; 51(12):2647-55. PMC: 3490490. DOI: 10.1111/j.1537-2995.2011.03210.x. View

Liseth K, Ersvaer E, Abrahamsen J, Nesthus I, Ryningen A, Bruserud O . Long-term cryopreservation of autologous stem cell grafts: a clinical and experimental study of hematopoietic and immunocompetent cells. Transfusion. 2009; 49(8):1709-19. DOI: 10.1111/j.1537-2995.2009.02180.x. View

Deol A, Lum L . Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited. Cancer Treat Rev. 2010; 36(7):528-38. PMC: 2921454. DOI: 10.1016/j.ctrv.2010.03.004. View

Akkok C, Liseth K, Nesthus I, Lokeland T, Tefre K, Bruserud O . Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation. Transfusion. 2008; 48(5):877-83. DOI: 10.1111/j.1537-2995.2008.01648.x. View

Antoniewicz-Papis J, Lachert E, Wozniak J, Janik K, Letowska M . Methods of freezing cord blood hematopoietic stem cells. Transfusion. 2013; 54(1):194-202. DOI: 10.1111/trf.12225. View

Kao G, Kim H, Daley H, Ritz J, Burger S, Kelley L . Validation of short-term handling and storage conditions for marrow and peripheral blood stem cell products. Transfusion. 2010; 51(1):137-47. DOI: 10.1111/j.1537-2995.2010.02758.x. View

10.

Liseth K, Abrahamsen J, Bjorsvik S, Grottebo K, Bruserud O . The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft. Cytotherapy. 2005; 7(4):328-33. DOI: 10.1080/14653240500238251. View

11.

Broxmeyer H, Cooper S . High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10 years. Clin Exp Immunol. 1997; 107 Suppl 1:45-53. View

12.

McIver Z, Melenhorst J, Wu C, Grim A, Ito S, Cho I . Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant. Haematologica. 2012; 98(3):346-52. PMC: 3659951. DOI: 10.3324/haematol.2012.072991. View

13.

Castelhano M, Reis-Alves S, Vigorito A, Rocha F, Pereira-Cunha F, De Souza C . Quantifying loss of CD34+ cells collected by apheresis after processing for freezing and post-thaw. Transfus Apher Sci. 2013; 48(2):241-6. DOI: 10.1016/j.transci.2013.01.017. View

14.

Galmes A, Besalduch J, Bargay J, Matamoros N, Duran M, Morey M . Cryopreservation of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide at -80 degrees C without rate-controlled freezing. Transfusion. 1996; 36(9):794-7. DOI: 10.1046/j.1537-2995.1996.36996420755.x. View

15.

Antonenas V, Garvin F, Webb M, Sartor M, Bradstock K, Gottlieb D . Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport. Cytotherapy. 2006; 8(2):158-65. DOI: 10.1080/14653240600620994. View

16.

Abbruzzese L, Agostini F, Durante C, Toffola R, Rupolo M, Rossi F . Long term cryopreservation in 5% DMSO maintains unchanged CD34(+) cells viability and allows satisfactory hematological engraftment after peripheral blood stem cell transplantation. Vox Sang. 2013; 105(1):77-80. DOI: 10.1111/vox.12012. View

17.

Valeri C, Pivacek L . Effects of the temperature, the duration of frozen storage, and the freezing container on in vitro measurements in human peripheral blood mononuclear cells. Transfusion. 1996; 36(4):303-8. DOI: 10.1046/j.1537-2995.1996.36496226141.x. View

18.

Steininger P, Smith R, Geier C, Zimmermann R, Eckstein R, Strasser E . Leukapheresis in non-cytokine-stimulated donors with a new apheresis system: first-time collection results and evaluation of subsequent cryopreservation. Transfusion. 2012; 53(4):747-56. DOI: 10.1111/j.1537-2995.2012.03787.x. View

19.

Galmes A, Besalduch J, Bargay J, Novo A, Morey M, Guerra J . Long-term storage at -80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant. Transfusion. 1999; 39(1):70-3. DOI: 10.1046/j.1537-2995.1999.39199116897.x. View

20.

Jansen J, Nolan P, Reeves M, Akard L, Thompson J, Dugan M . Transportation of peripheral blood progenitor cell products: effects of time, temperature and cell concentration. Cytotherapy. 2009; 11(1):79-85. DOI: 10.1080/14653240802666050. View